MylaPLai-GoldmanMD

Anatomic Pathology, Clinical Pathology

Co-Founder and Chairperson, GeneCentric Therapeutics

Dr. Lai-Goldman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1989
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pathology-Anatomic and Clinical, 1984 - 1988
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 1983 - 1984
Columbia University Vagelos College of Physicians and SurgeonsClass of 1983

PubMed

118 citations
Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape
Hawazin Faruki, Gregory Mayhew, Jonathan S. Serody, D. Neil Hayes, Charles M. Perou
Journal of Thoracic Oncology. 2017-06-01
152 citations
Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms☆
John D Day, Joseph A. DiGiuseppe, Charles J. Yeo, Myla Lai-Goldman, Steven M Anderson
Human Pathology. 1996-02-01
8 citations
THE CYTOBRUSH FOR EVALUATING ROUTINE CERVICOVAGINAL-ENDOCERVICAL SMEARS
M Lai-Goldman, R K Nieberg, D Mulcahy, E Wiesmeier
The Journal of Reproductive Medicine. 1990-10-01

Precision Cancer Drug Startup GeneCentric Acquires Nearby Select ImmunoGenomicsAugust 26th, 2019
RTP-Based GeneCentric Therapeutics Seeks Better Diagnostic Test for Head, Neck CancerAugust 19th, 2019
GeneCentric Therapeutics Acquires Select ImmunoGenomicsAugust 15th, 2019
Join now to see all